European equities traded in the US as American depositary receipts were falling significantly lower late Thursday morning, dropping 1.4% to 1,347.70 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company argenx (ARGX) and semiconductor company Sequans Communications (SQNS), which rose 3.8% and 2.6% respectively. They were followed by financial services company Banco Santander (SAN) and internet advertising firm Criteo (CRTO), which were up 2.1% and 2% respectively.
The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and brewing company Anheuser-Busch InBev (BUD), which lost 12% and 5.8% respectively. They were followed by 3D printer company Materialise (MTLS) and petroleum refiner Equinor (EQNR), which dropped 3.1% and 2.7% respectively.
From the UK and Ireland, the gainers were led by oil and gas company Shell (SHEL) and Adaptimmune Therapeutics (ADAP), which increased 1.7% and 0.9% respectively. They were followed by tobacco company British American Tobacco (BTI) and cruise line operator Carnival (CUK), which advanced 0.8% and 0.6% respectively.
The decliners from the UK and Ireland were led by medical device maker Smith & Nephew (SNN) and biopharmaceutical company TC Biopharm (TCBP), which tumbled 13.3% and 6.8% respectively. They were followed by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Amarin (AMRN), which fell 4% and 2.6% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。